Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Sensus Healthcare (SRTS) EBITDA Margin (2016 - 2025)

Sensus Healthcare (SRTS) has 10 years of EBITDA Margin data on record, last reported at 37.32% in Q3 2025.

  • For Q3 2025, EBITDA Margin fell 5423.0% year-over-year to 37.32%; the TTM value through Sep 2025 reached 15.25%, down 4416.0%, while the annual FY2024 figure was 19.35%, 2092.0% up from the prior year.
  • EBITDA Margin reached 37.32% in Q3 2025 per SRTS's latest filing, down from 26.56% in the prior quarter.
  • Across five years, EBITDA Margin topped out at 44.38% in Q4 2023 and bottomed at 86.09% in Q1 2023.
  • Average EBITDA Margin over 5 years is 0.13%, with a median of 13.21% recorded in 2024.
  • Peak YoY movement for EBITDA Margin: soared 21250bps in 2021, then plummeted -12410bps in 2023.
  • A 5-year view of EBITDA Margin shows it stood at 40.84% in 2021, then decreased by -22bps to 31.82% in 2022, then skyrocketed by 39bps to 44.38% in 2023, then crashed by -70bps to 13.21% in 2024, then plummeted by -383bps to 37.32% in 2025.
  • Per Business Quant database, its latest 3 readings for EBITDA Margin were 37.32% in Q3 2025, 26.56% in Q2 2025, and 31.71% in Q1 2025.